成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Mifamurtide

Mifamurtide Struktur
83461-56-7
CAS-Nr.
83461-56-7
Englisch Name:
Mifamurtide
Synonyma:
MIFAMURTIDE;MTP-PE;CGP 19835;MLV 19835;MTP-cephalin;L-MTP-PE. MTP-PE;CGP 19835A Lipid;Medchemexpress(MTP-PE);Mifamurtide (CGP-19835);muramyl tripeptide phosphatidylethanolamine
CBNumber:
CB11249151
Summenformel:
C59H109N6O19P
Molgewicht:
1237.52
MOL-Datei:
83461-56-7.mol

Mifamurtide Eigenschaften

Dichte
1.152
storage temp. 
-20°C
L?slichkeit
water: soluble2mg/mL, clear (warmed)
Aggregatzustand
powder
pka
1.39±0.50(Predicted)
Farbe
white to beige
InChIKey
ZVLWUMPAHCEZAW-HYGHKABSNA-N
CAS Datenbank
83461-56-7

Sicherheit

WGK Germany  3

Mifamurtide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Osteosarcoma.

Mechanism of action

Being a phospholipid, mifamurtide accumulates in the lipid bilayer of the liposomes upon infusion. After application of the liposomal infusion, the drug is cleared from the plasma within minutes. However, it is concentrated in lung, liver, spleen, nasopharynx and thyroid, and the terminal half-life is 18 hours, which is longer than the natural substance.

Clinical Use

Mifamurtide is an anticancer agent for the treatment of osteosarcoma, the most common primary malignancy of bone tissue mainly affecting children and adolescents. The drug was invented by Ciba-Geigy (now Novartis) in the early 1980s and the agent was subsequently licensed to Jenner Biotherapies in the 1990s. IDM Pharma bought the rights to the drug from Jenner in April 2003.In March 2009, mifamurtide was approved in the 27 European Union member states plus Iceland, Liechtenstein and Norway via a centralized marketing authorization. After the approval, IDM Pharma was acquired by Takeda, which began launching mifamurtide, as Mepact ®, in February 2010. Mifamurtide, a fully synthetic lipophilic derivative of muramyl dipeptide (MDP), is muramyl tripeptide phosphatidylethanolamine (MTP-PE), which is formulated as a liposomal infusion.

Nebenwirkungen

Mifamurtide is generally well tolerated; adverse events attributed to its administration include chills, fever, headache, nausea, and myalgias[1].

Mifamurtide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Mifamurtide Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 66)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Henan Bao Enluo International TradeCo.,LTD
+86-17331933971 +86-17331933971
deasea125996@gmail.com China 2472 58
Shandong Huizhihan Supply Chain Co., Ltd
+8613363081709
3957328362@qq.com China 300 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21634 55
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29880 58
Hubei Jusheng Technology Co.,Ltd.
18871490254
linda@hubeijusheng.com CHINA 28172 58
Chongqing Chemdad Co., Ltd
+86-023-6139-8061 +86-86-13650506873
sales@chemdad.com China 39894 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 32161 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 22787 58
BOC Sciences
16314854226; +16314854226
inquiry@bocsci.com United States 19741 58
Shanghai Acmec Biochemical Technology Co., Ltd.
+undefined18621343501
product@acmec-e.com China 33338 58

83461-56-7()Verwandte Suche:


  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
  • muramyl tripeptide phosphatidylethanolamine
  • N-(N-Acetylmuramoyl)-L-alanyl-D-alpha-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • CGP 19835
  • L-MTP-PE. MTP-PE
  • MLV 19835
  • MTP-cephalin
  • N-(N-Acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-L-alaninamide
  • muramyl tripeptide phosphatidylethanolamine liposome
  • L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-
  • N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine USP/EP/BP
  • CGP 19835A LIPID;MURAMYL TRIPEPTIDE PHOSPHATIDYLETHANOLAMINE LIPOSOME;L-MTP-PE;CGP-19835;MTP-PE;MTP-CEPHALIN;CGP19835;L-MTP-PE;MLV19835
  • CGP 19835A Lipid
  • Mifamurtide (CGP-19835)
  • MIFAMURTIDE
  • MTP-PE
  • Medchemexpress(MTP-PE)
  • 83461-56-7
Copyright 2019 ? ChemicalBook. All rights reserved